Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Схожие документы

• A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
  по: Yao, Min, et al.
  Опубликовано: (2014)
• Feasibility and Response of Concurrent Weekly Docetaxel with Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
  по: Jomon Raphael C, et al.
  Опубликовано: (2015-03-01)
• Feasibility and Response of Concurrent Weekly Docetaxel with Radical Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
  по: Raphael C, Jomon, et al.
  Опубликовано: (2015)
• Cardiovascular Risk and Prevention in Head and Neck Cancer Patients Treated with Radiotherapy
  по: Okoye, Christian C, et al.
  Опубликовано: (2016)
• Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
  по: Argiris, Athanassios, et al.
  Опубликовано: (2010)